News & Insights
Latest News
The content below contains the latest news affecting community pharmacy owners and their teams throughout Scotland. If you can't find something or you have a question please get in touch with us at webteam@cps.scot.
Can't find something?
Get in touch with the web team and we'll point you in the right direction.
Email webteam@cps.scot
PCA(P)(2025)23 - SSP Extension: Cefalexin Oral Suspension
SSP for cefalexin oral suspension sugar free products extended to 28 November 2025. Pharmacists should review updated guidance.
PCA(P)(2025)21 - Serious Shortage Protocol Extension: Cefalexin Oral Suspension
Serious Shortage Protocols for cefalexin oral suspension sugar free products extended to 24 Oct 2025. Applies to SSP077 and SSP078. Review updated guidance.
PCA(P)(2025)09: SSP Extensions for Estradot Patches and Cefalexin 125mg-5ml
This Circular advises community pharmacy contractors that the four UK-wide Serious Shortage Protocols (SSPs) for Estradot® (estradiol) transdermal patches, a hormone replacement therapy (HRT) product, due to expire on 2 May 2025 have been extended.
PCA(P)(2024)38 - 39: Serious Shortage Protocol for Cefalexin
Serious Shortage Protocols (SSP) in place for cefalexin 125mg / 5ml & 250mg / 5ml oral suspension sugar free, from 10 December 2024 to 31 January 2025.
PCA(P)(2024)22- Serious Shortage Protocol for Cefalexin 500mg Tabs
To advise of a Serious Shortage Protocol (SSP) in place for cefalexin 500mg tablets, from 6 August 2024 to 27 September 2024.